<i>DNMT3A/TET2</i> Mutant Clonal Hematopoiesis in Vexas Syndrome Results in DNA Hypomethylation and Transcriptional Activation of <i>WT1</i> and <i>MPL</i> Oncogenic Pathways
Jenna Fernandez(Mayo Clinic), Mrinal M. Patnaik(Mayo Clinic), Matthew J. Koster(Mayo Clinic in Arizona), Horatiu Olteanu(Mayo Clinic in Arizona), Terra Lasho(Mayo Clinic), Kenneth J. Warrington(Mayo Clinic), David B. Beck(Center for Human Genetics), Yael Kusne(WinnMed), Christy M. Finke(Mayo Clinic), Kaaren K. Reichard(Mayo Clinic), Bhavisha A. Patel(MACOM (United States)), Fernanda Gutierrez‐Rodrigues(National Heart Lung and Blood Institute), Peter C. Grayson(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Naseema Gangat(Mayo Clinic in Arizona), Neal S. Young(National Institutes of Health), Abhishek A. Mangaonkar(Mayo Clinic)
Cited by 4
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
|Journal of Clinical Oncology|2011|540
Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients
|Blood|2011|448
Inherited antithrombin deficiency: a review
|Haemophilia|2008|396